PT  - JOURNAL ARTICLE
AU  - Abalde-Atristain, Leire
TI  - GALvanizing Alzheimer’s disease therapy to combat the inflamed brain
AID  - 10.1126/scitranslmed.aax8310
DP  - 2019 May 08
TA  - Science Translational Medicine
PG  - eaax8310
VI  - 11
IP  - 491
4099  - http://stm.sciencemag.org/content/11/491/eaax8310.short
4100  - http://stm.sciencemag.org/content/11/491/eaax8310.full
AB  - Galectin-3 is elevated in patients with Alzheimer’s disease (AD), and its deletion reduces neuroinflammation and β-amyloid burden in a mouse model of AD.